Stocktoria

Hyperfine, Inc. HYPR

Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2021-01-27
Chart by TradingView
4/9
Piotroski F — financial health
-16.31
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$13.6M$12.9M$11.0M$6.8M$1.5M
Gross profit$6.8M$5.9M$4.8M$907,000-$1.2M
Operating income-$37.1M-$43.2M-$48.1M-$73.9M-$64.9M
Net income-$35.6M-$40.7M-$44.2M-$44.2M-$64.9M
Operating cash flow-$27.9M-$38.8M-$41.8M-$72.3M-$47.2M
Free cash flow-$29.1M-$39.1M-$42.6M-$72.9M-$49.9M
Total assets$55.3M$58.9M$94.2M$134.1M$202.5M
Total liabilities$14.3M$9.9M$9.8M$10.3M$16.2M
Shareholders' equity$41.0M$49.0M$84.4M$123.7M$186.2M
Ratios
Gross margin49.8%45.7%43.1%13.3%-78.0%
Operating margin-273.4%-335.3%-436.1%-1084.2%-4336.1%
Net margin-262.3%-315.9%-401.0%-649.2%-4335.0%
FCF margin-214.8%-303.7%-386.3%-1070.2%-3335.1%
Return on assets-64.4%-69.1%-47.0%-33.0%-32.0%
Return on equity-86.8%-83.0%-52.4%-35.8%-34.8%
Debt / equity0.00×
Current ratio4.346.1510.1414.6212.55
Revenue growth5.2%16.8%61.9%355.5%408.8%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC730,233$788,652

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -16.31 (distress)

  • Working capital / assets 0.709
  • Retained earnings / assets -5.972
  • EBIT / assets -0.671
  • Equity / liabilities 2.876

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001833769 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.